Key stats
Market capitalization
3.149BINR
Dividends yield (FY)
1.75%
Price to earnings Ratio (TTM)
14.55
Basic EPS (TTM)
47.35INR
ISIN
INE354A01013
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
jenburkt.com
CEO
Ashish Uttam Bhuta
Headquarters
Mumbai
Employees
730
Founded
1985
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The firm offers anthelmintic, anti-osteoporotic, anti-arthritic, anti-ulcerants, antibiotics, aphrodisiac, anti-cough, and cold and allergy dermatological products. It operates through the following segments: Local and Exports. The company was founded by Hemendra N. Bhuta, Uttambhai Nandlal Bhuta and Harshad N. Bhuta on June 10, 1985 and is headquartered in Mumbai, India.
Jenburkt Pharma: Long Term Strategy- Suitable for InvestorsJenburkt Pharma: Long Term Strategy Suitable for Investors
The stock is currently in reversal mode. Will show uptrend in coming days. May consider this stock for long duration.
Disclaimer: It is not my recommendation and it is only my view on this stock. Research and consult with your financial advi
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
Revenue